Condition | Drugs |
Blistering disorder characterized as a paraneoplastic pemphigus-like phenomenon | Fludarabine |
Raynaud's phenomenon | Bleomycin, vinblastine, vincristine, BEP, PVB, MOPP, ABVD |
Dermatomyositis-like reaction | Hydroxyurea (chronic), tamoxifen, tegafur |
Folliculitis | Dactinomycin, fluorouracil, methotrexate |
Porphyria | Busulfan, chlorambucil, cisplatin, cyclophosphamide, methotrexate |
Telangiectasia | Carmustine (topical), hydroxyurea |
Lichenoid eruption | Hydroxyurea, tegafur |
Inflammation of benign lesions | Cisplatin, dacarbazine, dactinomycin, doxorubicin, fluorouracil, vincristine, capecitabine |
Reactivation of varicella-zoster infection | Bortezomib |
Eosinophilic cellulitis | Cladribine |
Histiocytic dermatosis | Cytarabine, methotrexate |
Leg ulcers | Hydroxyurea |